Danaher Corporation (DHR) Stock Analysis
Falling Knife setup
Healthcare · Diagnostics & Research
Sell if holding. Momentum 1.2/10 is below the 5.0 floor at $179.58 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Geographic: non-U.S. customers (59.0%); Weak growth.
Danaher is a global science and technology company organized in Biotechnology, Life Sciences, and Diagnostics segments, selling products on a recurring basis through a direct sales model to a geographically diverse customer base in approximately 50 countries. In 2025,... Read more
Sell if holding. Momentum 1.2/10 is below the 5.0 floor at $179.58 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Geographic: non-U.S. customers (59.0%); Weak growth. Chart setup: Death cross, below all MAs, RSI 38, MACD bearish. Score 5.0/10, moderate confidence.
Passes 5/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, earnings proximity 82d clear, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHGeographicnon-U.S. customers59%10-K Item 1A: 'In 2025 approximately 59% of our sales from continuing operations were derived from customers outside the U.S.'
- LOWGeographicChina11%10-K Item 1A: 'In 2025 we generated approximately 11% of our sales from continuing operations from China'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
3 floor-breakers
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Momentum 1.2/10 is below the 5.0 floor at $179.58 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Geographic: non-U.S. customers (59.0%); Weak growth. Chart setup: Death cross, below all MAs, RSI 38, MACD bearish. Prior stop was $169.75. Score 5.0/10, moderate confidence.
Take-profit target: $225.12 (+25.2% upside). Prior stop was $169.75. Stop-loss: $169.75.
Concentration risk — Geographic: non-U.S. customers (59.0%); Weak growth; Negative momentum.
Danaher Corporation trades at a P/E of 34.6 (forward 19.7). TrendMatrix value score: 6.0/10. Verdict: Sell.
30 analysts cover DHR with a consensus score of 4.2/5. Average price target: $250.
What does Danaher Corporation do?Danaher is a global science and technology company organized in Biotechnology, Life Sciences, and Diagnostics segments,...
Danaher is a global science and technology company organized in Biotechnology, Life Sciences, and Diagnostics segments, selling products on a recurring basis through a direct sales model to a geographically diverse customer base in approximately 50 countries. In 2025, approximately 59% of continuing operations sales were from outside the U.S.; the Danaher Business System guides continuous improvement across more than 15 operating companies.